Skip to main content

Recombinant Human Annexin V/ANXA5 protein is a Human Full Length protein, in the 1 to 320 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, WB.


Images

SDS-PAGE - Recombinant Human Annexin V/ANXA5 protein (AB89493), expandable thumbnail
  • Western blot - Recombinant Human Annexin V/ANXA5 protein (AB89493), expandable thumbnail

Publications

Key facts

Purity
>95% SDS-PAGE
Expression system
Escherichia coli
Tags
Tag free
Applications
SDS-PAGE, WB
Biologically active
No

Reactivity data

Application
SDS-PAGE
Reactivity
Reacts
Dilution info
-
Notes

-

Application
WB
Reactivity
Reacts
Dilution info
-
Notes

ab89493 can be used as a WB positive control in conjunction with ab30941.

Associated Products

Select an associated product type

4 products for Alternative Product

Target data

Function

The protein expressed by gene ANXA5 is an anticoagulant protein that indirectly inhibits the thromboplastin-specific complex, a component involved in the blood coagulation cascade. This supplementary information is collated from multiple sources and compiled automatically.

Alternative names

Recommended products

Recombinant Human Annexin V/ANXA5 protein is a Human Full Length protein, in the 1 to 320 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, WB.

Key facts

Purity
>95% SDS-PAGE
Expression system
Escherichia coli
Applications
SDS-PAGE, WB
Accession
P08758-1
Animal free
No
Species
Human
Concentration
Loading...
Storage buffer

pH: 8
Constituents: 10% Glycerol (glycerin, glycerine), 0.316% Tris HCl, 0.0154% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

Sequence info

Amino acid sequence

Accession
P08758
Protein length
Full Length
Amino acids
1 to 320
Nature
Recombinant

Specifications

Form
Liquid
Additional notes

ab89493 is purified using conventional chromatography techniques.

General info

Function

The protein expressed by gene ANXA5 is an anticoagulant protein that indirectly inhibits the thromboplastin-specific complex, a component involved in the blood coagulation cascade.

This supplementary information is collated from multiple sources and compiled automatically.

Sequence similarities

Belongs to the annexin family.

Post-translational modifications

S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex.

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

This product was previously labelled as Annexin V

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Annexin V also known as ANXA5 is a protein with a mass of approximately 35-36 kDa. This protein belongs to the annexin family which includes proteins capable of binding to phospholipids in a calcium-dependent manner. Annexin V is mostly expressed in placental tissue though it can be found in various other tissues like the vascular endothelium. Researchers often utilize annexin V for staining dead cells or identifying apoptosis using assays such as annexin V FITC or 7-AAD staining. It forms part of the annexin V binding buffer which enhances its binding affinity.

Biological function summary

Annexin V has an important role in cell membrane dynamics and signaling. The protein does not function as part of a larger complex but its ability to bind negatively charged phospholipids like phosphatidylserine makes it important in apoptosis. During apoptosis phosphatidylserine translocates to the outer leaflet of the plasma membrane where annexin V marks these apoptotic cells. This property enables annexin V-based assays to detect early stages of apoptosis.

Pathways

Annexin V involvement is seen in pathways associated with blood coagulation and apoptosis. In the apoptosis pathway annexin V interacts with apoptotic markers to identify dying cells. It relates to proteins such as caspases which are key executors of apoptosis. In coagulation annexin V has been shown to interact with prothrombinase complex and can affect calcium ion concentration thereby influencing blood clotting processes.

Associated diseases and disorders

Annexin V plays a role in antiphospholipid syndrome and cardiovascular diseases. Annexin V has been researched for its connection to antiphospholipid antibodies where it affects normal annexin V function impacting clot formation. In cardiovascular diseases annexin V can interact with proteins such as thrombomodulin influencing thrombotic and atherosclerotic pathways. Understanding these interactions helps researchers develop potential therapeutic approaches for related conditions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • SDS-PAGE - Recombinant Human Annexin V/ANXA5 protein (ab89493), expandable thumbnail

    SDS-PAGE - Recombinant Human Annexin V/ANXA5 protein (ab89493)

    SDS-PAGE analysis of Recombinant Human Annexon V protein (ab89493), under reducing conditions. Proteins visualized by coomassie blue stain.

    Lane 1: Molecular Weight Standards

    Lane 2: 3 μg Recombinant Human Annexon V protein

  • Western blot - Recombinant Human Annexin V/ANXA5 protein (ab89493), expandable thumbnail

    Western blot - Recombinant Human Annexin V/ANXA5 protein (ab89493)

    All lanes: Anti-Annexin V antibody (ab30941) at 1 µg/mL

    All lanes: Western blot - Recombinant Human Annexin V/ANXA5 protein (ab89493) at 0.1 µg

    Secondary

    All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (Goat Anti-Rabbit IgG H&L (HRP) preadsorbed ab97080) at 1/5000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Exposure time: 20s

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com